| Ms Patricia Gonzalez, APN | |
|
435 South St Ste 210, Morristown, NJ 07960-6422 | |
| (973) 971-7165 | |
| (973) 290-7675 |
| Full Name | Ms Patricia Gonzalez |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 435 South St Ste 210, Morristown, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083156996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 26NJ00681800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atlantic Home Care & Hospice | Morristown, NJ | Home health agency |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Overlook Medical Center | Summit, NJ | Hospital |
| Skilled Nursing At Fellowship Village | Basking ridge, NJ | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
As the debate over healthcare insurance reform continues, faculty members of The George Washington University Medical Center are available to comment on topics regarding health insurance reform, including: general policy/political analysis, Medicare, Medicaid, compliance, community health centers, state health reform, affordability, finance and health technology information.
A recent study by Kansas State University virologists demonstrates successful postinfection treatment for SARS-CoV-2, the virus that causes COVID-19.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
A living will or advance directive for end of life care may soon be worthless documents in Idaho if state legislators have their way – and that's news that has older Idahoans outraged.
Investigators found similarities in the bacterial composition of the mouth among patients with early rheumatoid arthritis and those at risk of developing the disease, compared with healthy individuals who were not at risk. The findings come from a study published in Arthritis & Rheumatology.
› Verified 2 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
As the debate over healthcare insurance reform continues, faculty members of The George Washington University Medical Center are available to comment on topics regarding health insurance reform, including: general policy/political analysis, Medicare, Medicaid, compliance, community health centers, state health reform, affordability, finance and health technology information.
A recent study by Kansas State University virologists demonstrates successful postinfection treatment for SARS-CoV-2, the virus that causes COVID-19.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
A living will or advance directive for end of life care may soon be worthless documents in Idaho if state legislators have their way – and that's news that has older Idahoans outraged.
Investigators found similarities in the bacterial composition of the mouth among patients with early rheumatoid arthritis and those at risk of developing the disease, compared with healthy individuals who were not at risk. The findings come from a study published in Arthritis & Rheumatology.
› Verified 2 days ago
| Entity Name | Center For Diagnosis And Treatment, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831213693 PECOS PAC ID: 1557370129 Enrollment ID: O20060410000231 |
News Archive
As the debate over healthcare insurance reform continues, faculty members of The George Washington University Medical Center are available to comment on topics regarding health insurance reform, including: general policy/political analysis, Medicare, Medicaid, compliance, community health centers, state health reform, affordability, finance and health technology information.
A recent study by Kansas State University virologists demonstrates successful postinfection treatment for SARS-CoV-2, the virus that causes COVID-19.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
A living will or advance directive for end of life care may soon be worthless documents in Idaho if state legislators have their way – and that's news that has older Idahoans outraged.
Investigators found similarities in the bacterial composition of the mouth among patients with early rheumatoid arthritis and those at risk of developing the disease, compared with healthy individuals who were not at risk. The findings come from a study published in Arthritis & Rheumatology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Patricia Gonzalez, APN Po Box 416457, Boston, MA 02241-6457 Ph: (844) 362-1735 | Ms Patricia Gonzalez, APN 435 South St Ste 210, Morristown, NJ 07960-6422 Ph: (973) 971-7165 |
News Archive
As the debate over healthcare insurance reform continues, faculty members of The George Washington University Medical Center are available to comment on topics regarding health insurance reform, including: general policy/political analysis, Medicare, Medicaid, compliance, community health centers, state health reform, affordability, finance and health technology information.
A recent study by Kansas State University virologists demonstrates successful postinfection treatment for SARS-CoV-2, the virus that causes COVID-19.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
A living will or advance directive for end of life care may soon be worthless documents in Idaho if state legislators have their way – and that's news that has older Idahoans outraged.
Investigators found similarities in the bacterial composition of the mouth among patients with early rheumatoid arthritis and those at risk of developing the disease, compared with healthy individuals who were not at risk. The findings come from a study published in Arthritis & Rheumatology.
› Verified 2 days ago
Valeria Dworkowitz, DNP, RN, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 55 Madison Ave Ste 400, Morristown, NJ 07960 Phone: 973-409-1065 Fax: 937-215-3157 | |
Megan Lynn Cathey, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Madison Ave, Morristown, NJ 07960 Phone: 973-971-5358 | |
Abigail Ruth Dean, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Madison Ave Ste 4101, Morristown, NJ 07960 Phone: 973-644-4844 | |
Megan Ruth Filoramo, APRN-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 310 Madison Ave, Suite 301, Morristown, NJ 07960 Phone: 973-998-9200 Fax: 973-998-9201 | |
Laura Natoli, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 131 Madison Ave, Morristown, NJ 07960 Phone: 973-326-9000 | |
Mr. Jacqueline Elizabeth Fearon-clarke, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 95 Madison Ave, Suite 411, Morristown, NJ 07960 Phone: 973-971-4179 Fax: 973-290-7905 | |
Mrs. Tara Gerise Gleeson, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Madison Ave, Morristown, NJ 07960 Phone: 973-971-6473 Fax: 973-290-7164 |